BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31683399)

  • 1. [The association between the whole blood riboflavin level and the occurrence, development and prognosis of esophageal squamous cell carcinoma].
    Li SS; Tan HZ; Xu YW; Wu ZY; Wu JY; Zhao XK; Wang LD; Long L; Li EM; Xu LY; Zhang JJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1124-1129. PubMed ID: 31683399
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Riboflavin Level is Associated with Risk, Relapse, and Survival of Esophageal Squamous Cell Carcinoma.
    Li SS; Xu YW; Wu JY; Tan HZ; Wu ZY; Xue YJ; Zhang JJ; Li EM; Xu LY
    Nutr Cancer; 2017 Jan; 69(1):21-28. PubMed ID: 27898225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between the time of neutrophils to the lowest and prognosis of patients with esophageal squamous cell carcinoma treated with non-operative therapy].
    Liu S; Huang LP; Lin Z; Liu YF; Zheng ZR; Peng XE; Chen WL; Hu ZJ
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):124-128. PubMed ID: 30862142
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
    Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
    Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
    Lv X; Han S; Xu B; Deng Y; Feng Y
    BMC Cancer; 2021 Sep; 21(1):1072. PubMed ID: 34592957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
    Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of red cell distribution width in esophageal squamous cell carcinoma.
    Hirahara N; Tajima Y; Fujii Y; Hyakudomi R; Yamamoto T; Ishitobi K; Taniura T; Kawabata Y
    J Surg Res; 2018 Oct; 230():53-60. PubMed ID: 30100040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
    BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC.
    Yang J; Kong P; Yang J; Jia Z; Hu X; Wang Z; Cui H; Bi Y; Qian Y; Li H; Wang F; Yang B; Yan T; Ma Y; Zhang L; Cheng C; Song B; Li Y; Xu E; Liu H; Gao W; Wang J; Liu Y; Zhai Y; Chang L; Wang Y; Zhang Y; Shi R; Liu J; Wang Q; Cheng X; Cui Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818781405. PubMed ID: 29950151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
    Lei Z; Tian D; Zhang C; Zhao S; Su M
    BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.
    Ainiwaer J; Tuerhong A; Hasim A; Chengsong D; Liwei Z; Sheyhidin I
    Mol Biol Rep; 2013 May; 40(5):3769-75. PubMed ID: 23275236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China.
    He Y; Ye L; Shan B; Song G; Meng F; Wang S
    Asian Pac J Cancer Prev; 2009; 10(4):619-22. PubMed ID: 19827881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.
    Wu SX; Li XY; Xu HY; Xu QN; Luo HS; Du ZS; Huang HC; Wu ZY
    Sci Rep; 2017 Dec; 7(1):16870. PubMed ID: 29203855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison and significance of plasma riboflavin levels in patients with esophageal squamous cell carcinoma versus Linzhou healthy migrants in Changzhi of Shanxi].
    Ji AF; Wei W; Wang JS; Wei ZB; Lian CH; Yang JZ; Zhao L; Ma L; Ma L; Qin XQ; He XF; Wang LD
    Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1048-50. PubMed ID: 22333176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.